VVOS earnings
Vivos Therapeutics (VVOS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- VVOS beat EPS estimates in 9 of its last 17 reports.
VVOS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | -0.07 | -0.30 | 76.67% | $6.41M |
| Q2 2026 | Aug 14, 2026 | -0.31 | -0.41 | 24.39% | $5.15M |
| Q1 2026 | May 20, 2026 | -0.52 | -0.45 | -15.56% | $5.14M |
| Q1 2026 | Apr 15, 2026 | -0.58 | -0.49 | -17.17% | $5.14M |
| Q3 2025 | Nov 19, 2025 | -0.49 | -0.53 | 7.55% | $6.78M |
| Q2 2025 | Aug 19, 2025 | -0.55 | -0.27 | -103.70% | $3.82M |
| Q1 2025 | May 15, 2025 | -0.45 | -0.44 | -2.27% | $3.02M |
| Q4 2024 | Mar 31, 2025 | -0.28 | -0.43 | 34.88% | $3.70M |
| Q3 2024 | Nov 14, 2024 | -0.40 | -0.70 | 42.86% | $3.86M |
| Q2 2024 | Aug 14, 2024 | -0.60 | -1.05 | 42.86% | $4.05M |
| Q1 2024 | May 14, 2024 | -1.63 | -1.17 | -39.32% | $3.42M |
| Q4 2023 | Mar 28, 2024 | -3.05 | -1.90 | -60.53% | $3.25M |
| Q3 2023 | Nov 14, 2023 | -1.75 | -3.12 | 43.91% | $3.30M |
| Q2 2023 | Aug 14, 2023 | -3.75 | -3.75 | 0.00% | $3.40M |
| Q1 2023 | Jun 8, 2023 | -1.72 | -0.18 | -855.56% | $3.86M |
| Q4 2022 | Mar 30, 2023 | -5.00 | -5.50 | 9.09% | $3.95M |
| Q3 2022 | Dec 20, 2022 | -8.25 | -0.28 | -2846.43% | $4.25M |